Related Experiment Video
Updated: Jun 2, 2026

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle
Published on: March 5, 2019
Casein kinase 2 regulates the mRNA-destabilizing activity of tristetraprolin
Won Hyeok Lee1, Hyun Hee Lee, Mai-Tram Vo
1Department of Biological Sciences, University of Ulsan, Ulsan 680-749, Korea.
Abstract:
Tristetraprolin (TTP) is an AU-rich element-binding protein that regulates mRNA stability. We previously showed that TTP acts as a negative regulator of VEGF gene expression in colon cancer cells. The p38 MAPK pathway is known to suppress the TTP activity. However, until now the signaling pathway to enhance TTP function is not well known. Here, we show that casein kinase 2 (CK2) enhances the TTP function in the regulation of the VEGF expression in colon cancer cells. CK2 increased TTP protein levels and enhanced VEGF mRNA decaying activity of TTP. TTP was not a direct target of CK2. Instead, CK2 increased the phosphorylation of MKP-1, which led to a decrease in the phosphorylation of p38 MAPK. Inhibition of MKP-1 by siRNA attenuated the increase in TTP function and the decrease of p38 phosphorylation induced by CK2α overexpression. TGF-β1 increased the expressions of CK2 and TTP and the TTP function. The siRNA against CK2α or TTP reversed TGF-β1-induced increases in the expression of CK2 and TTP and the TTP function. Our data suggest that CK2 enhances the protein level and activity of TTP via the modulation of the MKP-1-p38 MAPK signaling pathway and that TGF-β1 enhances the activity of CK2.
Insights
Casein kinase 2 (CK2) enhances tristetraprolin (TTP) function in colon cancer by modulating the MKP-1-p38 MAPK pathway, increasing TTP levels and VEGF mRNA decay. TGF-β1 also boosts CK2 and TTP activity.
Area of Science:
- Molecular Biology
- Cancer Research
- Signal Transduction
Background:
- Tristetraprolin (TTP) is an AU-rich element-binding protein regulating mRNA stability and acts as a negative regulator of VEGF gene expression in colon cancer.
- The p38 MAPK pathway is known to suppress TTP activity, but pathways enhancing TTP function remain largely unknown.
Purpose of the Study:
- To investigate the signaling pathway that enhances TTP function in regulating VEGF expression in colon cancer cells.
- To elucidate the role of casein kinase 2 (CK2) in modulating TTP activity and its downstream effects.
Main Methods:
- Investigated the effect of CK2 on TTP protein levels and VEGF mRNA decay activity.
- Utilized siRNA to inhibit MKP-1 and assessed its impact on TTP function and p38 MAPK phosphorylation.
- Examined the influence of TGF-β1 on CK2 and TTP expression and function, and the effect of siRNA against CK2α or TTP.
Main Results:
- CK2 was found to enhance TTP function by increasing TTP protein levels and augmenting TTP's VEGF mRNA decaying activity.
- CK2 enhanced TTP function indirectly by increasing MKP-1 phosphorylation, which decreased p38 MAPK phosphorylation.
- siRNA-mediated inhibition of MKP-1 attenuated CK2-induced increases in TTP function and p38 phosphorylation.
- TGF-β1 increased CK2 and TTP expression and TTP function; siRNA against CK2α or TTP reversed these effects.
Conclusions:
- CK2 enhances TTP protein levels and activity through modulation of the MKP-1-p38 MAPK signaling pathway.
- TGF-β1 enhances CK2 activity, which in turn enhances TTP function in colon cancer cells.
Related Concept Videos
Destabilization of Microtubules
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
PI3K/mTOR/AKT Signaling Pathway
The Unfolded Protein Response
Regulation of the Unfolded Protein Response

